Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III NPC-25 in pediatric hypozincemia (NPC-25-6)
jRCT2031240295Phase 3Active, not recruiting
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of zinc histidine hydrate in zinc deficiency, sponsored by Nobelpharma Co., Ltd. Started Dec 2024; status: active, not recruiting.
02
Drugs
zinc histidine hydrate
03
Conditions
zinc deficiency
Beyond the preview
Go deeper on jRCT2031240295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240295.